Topic

Webcasts

Webinar Date/Time: Wed, Nov 30, 2022 10:00 AM EST


De-risking DCTs with Quality Systems

Articles

Dr. Pratik Darji, Head of Progressive Clinical Research Solutions in Gujarat, India discusses the state of clinical trials in the country.

Indian Sites Share Challenges as Clinical Trials Grow

Vice President, Sites and Patients Center of Excellence, PPD Clinical Research, Themo Fisher Scientific

Vice President, Head of Development Operations-Biopharma, PPD Clinical Research, Thermo Fisher Scientific

A more crowded space is presenting new challenges for stakeholders that must be addressed to improve efficiency.

Make Your Clinical Trial a Priority in a Busy Landscape

Fan Gao, PhD, MS, is part of the ZS R&D excellence leadership team. She leads the digital and DCT vertical in clinical development.

Arnab Roy is a leader in ZS’s R&D excellence practice area and leads the development and global commercialization of ZS's DCT strategy and analytics solutions.

Ankur Vasudeva is a leader in ZS’s R&D excellence practice area and leads strategy and analytics work in the areas of DCT and clinical feasibility.

William Chaplin is a consultant for ZS's R&D excellence team and member of the digital and DCT vertical in clinical development.

Sites not expected to fade away even as DCTs continue to grow past COVID-19.

Adapting Site Selection for Clinical Trial Decentralization and the Future Landscape

Helping physicians and patients discuss local trials at the point of care.

The Missing Link in Clinical Trial Recruitment

ClinOne Founder and Chief Solutions Officer

Sponsors and CROs can ease the burdens of patients, sites, and physicians by identifying these 3 key areas.

Empowering Sites to Optimize Clinical Trial Performance

Senior Director, Global Feasibility, Labcorp Drug Development Inc.

Senior Director Patient Insights and Solutions, Portfolio Transformation and Insights, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Director Oncology Hematology, Janssen Research & Development, LLC

Kenneth Getz is a senior research fellow at the Tufts Center for the Study of Drug Development.

2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.

Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce

Aasma Shaukat, MD, MPH, study co-lead, professor of medicine, and director of outcomes research for the Division of Gastroenterology and Hepatology at New York University Langone Health discusses how sites have evolved since COVID-19.

How Study Sites Experienced Clinical Trial Changes During Pandemic

Department of Medicine, Stanford University School of Medicine, Stanford, CA

Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland OH

Industry must act now to minimize effects of COVID-19 on clinical research.

Pandemic Challenges and Opportunities for Gender Equity in Clinical Research

In new age of digital, investigators must carefully create strategies to keep engagement high.

Investigative Sites